Are you Dr. Peppercorn?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 74 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
101 Manning Dr
Chapel Hill, NC 27514Phone+1 919-966-4996Fax+1 919-843-5515
Summary
- Dr. Amanda Peppercorn, MD is an infectious disease specialist in Chapel Hill, North Carolina. She is currently licensed to practice medicine in North Carolina and Massachusetts.
Education & Training
Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 2002 - 2005- Massachusetts General HospitalResidency, Internal Medicine, 1998 - 2001
Harvard Medical SchoolClass of 1998
Certifications & Licensure
MA State Medical License 2001 - 2025
NC State Medical License 2005 - 2018- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP) Start of enrollment: 2006 May 01
Publications & Presentations
PubMed
- 137 citationsSafety, tolerability, and pharmacokinetics of the HIV integrase inhibitor dolutegravir given twice daily with rifampin or once daily with rifabutin: results of a phase...Kelly E. Dooley, Patrick Sayre, Julie Borland, Elizabeth Purdy, Shuguang Chen
Journal of Acquired Immune Deficiency Syndromes. 2013-01-01 - 42 citationsPreventing healthcare-associated Aspergillus infections: review of recent CDC/HICPAC recommendationsDavid J. Weber, Amanda Peppercorn, Melissa B. Miller, Emily Sickbert-Benett, William A. Rutala
Medical Mycology. 2009-03-09 - 13 citationsEffect of Prednisone on the Pharmacokinetics of the Integrase Inhibitor DolutegravirIvy Song, Julie Borland, Shuguang Chen, Paul Savina, Amanda Peppercorn
Antimicrobial Agents and Chemotherapy. 2013-09-01
Press Mentions
'Like Somebody Gave Me a Happy Pill:' Monoclonal Antibodies Are Helping the Americans Most at Risk for COVID-19April 17th, 2021- To Get Ahead of Variants, Covid-19 Drug Makers Use Evolutionary Biology as a GuideFebruary 20th, 2021
